Opioid dependence latent structure: two classes with differing severity?

Grants

Funding Acknowledgements

Louisa Degenhardt received an untied educational grant from Reckitt Benckiser to examine the extent of misuse, diversion and injection of buprenorphine-naloxone in Australia, 2006-08. The design, conduct, interpretation and reporting of the post-marketing surveillance studies' findings were determined by the study investigators; the funder had no role in these. The funder also had no role in or knowledge of the conception and writing of this particular manuscript. We declare that we have no conflicts of interest.This study was funded by NIDA (grant no. 5 R01 DA017305-02). The authors thank the treatment agencies and the research participants for their support of this study. We also thank Elizabeth Conroy, Elizabeth Maloney, Michelle Torok, Caitlin McCue and Cherie Kam for assistance with data collection. Finally, thank you to Richard Mattick of NDARC and to the collaborating research centres.